ACS Chemical Biology · 2017 · 119 citations · 11 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryMolecular OncologyActivity-based Protein ProfilingFragment-based Lead DiscoveryHit-to-lead OptimizationLead DiscoveryProtein-ligand BindingProtein-ligand InteractionsCysteine ConjugationCysteine OxidationFragment-based Covalent ScreeningFragment-based Ligand DesignLigand-based ScreeningLigand-target Binding PredictionPancreatic Cancer PharmacotherapySelective Cancer Therapy
Chemical genetic screening of small-molecule libraries has been a promising strategy for discovering unique and novel therapeutic compounds. However, identifying the targets of lead molecules that arise from these screens has remained a major bottleneck in understanding the mechanism of action of these compounds. Here, we have coupled the screening of a cysteine-reactive fragment-based covalent ligand library with an isotopic tandem orthogonal proteolysis-enabled activity-based protein profiling (isoTOP-ABPP) chemoproteomic platform to rapidly couple the discovery of lead small molecules that impair pancreatic cancer pathogenicity with the identification of druggable hotspots for potential cancer therapy. Through this coupled approach, we have discovered a covalent ligand DKM 2-93 that impairs pancreatic cancer cell survival and in vivo tumor growth through covalently modifying the catalytic cysteine of the ubiquitin-like modifier activating enzyme 5 (UBA5), thereby inhibiting its activity as a protein that activates the ubiquitin-like protein UFM1 to UFMylate proteins. We show that UBA5 is a novel pancreatic cancer therapeutic target and show DKM 2-93 as a relatively selective lead inhibitor of UBA5. Our results underscore the utility of coupling the screening of covalent ligand libraries with isoTOP-ABPP platforms for mining the proteome for druggable hotspots for cancer therapy.
11
Quantitative reactivity profiling predicts functional cysteines in proteomes
Eranthie Weerapana, Chu Wang, Gabriel M. Simon et al. · Nature · 2010 · 1.7K citations · Full text
Proteome-wide covalent ligand discovery in native biological systems
Keriann M. Backus, Bruno E. Correia, Kenneth M. Lum et al. · Nature · 2016 · 978 citations
ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity
Tao Xu, S.K. Park, John D. Venable et al. · Journal of Proteomics · 2015 · 587 citations · Full text
Modification of ASC1 by UFM1 Is Crucial for ERα Transactivation and Breast Cancer Development
Hee Min Yoo, Sung Hwan Kang, Jae Yeon Kim et al. · Molecular Cell · 2014 · 228 citations · Full text